On February 21, 2025, the US Food and Drug Administration (FDA) revised its shortage categorization of semaglutide, a glucagon-like peptide 1 ...

Last month, the U.S. Food and Drug Administration (the “FDA”) announced in a Declaratory Order the resolution of the shortage of semaglutide ...

The Food and Drug Administration (FDA) has approved a few forms of semaglutide for treating type ... Otherwise, you should stick to your usual dosing schedule. You should not give yourself an ...

Novo Nordisk's late stage diabetes candidate semaglutide ... more convenient weekly dosing schedule. Novo is also developing semaglutide in a patient-friendly pill form. Launched in 2015 ...

Ozempic and Wegovy, the widely popular forms of semaglutide sold to treat diabetes and obesity, have officially been removed from the Food and Drug Administration’s (FDA) drug shortage list ...